BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 34509861)

  • 1. SAR of novel benzothiazoles targeting an allosteric pocket of DENV and ZIKV NS2B/NS3 proteases.
    Maus H; Barthels F; Hammerschmidt SJ; Kopp K; Millies B; Gellert A; Ruggieri A; Schirmeister T
    Bioorg Med Chem; 2021 Oct; 47():116392. PubMed ID: 34509861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Inhibition of NS2B/NS3 Protease: A New Therapeutic Opportunity to Treat Dengue and Zika Virus Infection.
    Starvaggi J; Previti S; Zappalà M; Ettari R
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SAR evolution towards potent C-terminal carboxamide peptide inhibitors of Zika virus NS2B-NS3 protease.
    Colarusso S; Ferrigno F; Ponzi S; Pavone F; Conte I; Abate L; Beghetto E; Missineo A; Amaudrut J; Bresciani A; Paonessa G; Tomei L; Montalbetti C; Bianchi E; Toniatti C; Ontoria JM
    Bioorg Med Chem; 2022 Mar; 57():116631. PubMed ID: 35123179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the Zika virus two-component NS2B-NS3 protease and structure-assisted identification of allosteric small-molecule antagonists.
    Shiryaev SA; Farhy C; Pinto A; Huang CT; Simonetti N; Elong Ngono A; Dewing A; Shresta S; Pinkerton AB; Cieplak P; Strongin AY; Terskikh AV
    Antiviral Res; 2017 Jul; 143():218-229. PubMed ID: 28461069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proline-Based Allosteric Inhibitors of Zika and Dengue Virus NS2B/NS3 Proteases.
    Millies B; von Hammerstein F; Gellert A; Hammerschmidt S; Barthels F; Göppel U; Immerheiser M; Elgner F; Jung N; Basic M; Kersten C; Kiefer W; Bodem J; Hildt E; Windbergs M; Hellmich UA; Schirmeister T
    J Med Chem; 2019 Dec; 62(24):11359-11382. PubMed ID: 31769670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic Interactions of Post Cleaved NS2B Cofactor and NS3 Protease Identified by Integrative Structural Approaches.
    Quek JP; Ser Z; Chew BLA; Li X; Wang L; Sobota RM; Luo D; Phoo WW
    Viruses; 2022 Jun; 14(7):. PubMed ID: 35891424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allosteric quinoxaline-based inhibitors of the flavivirus NS2B/NS3 protease.
    Zephyr J; Rao DN; Johnson C; Shaqra AM; Nalivaika EA; Jordan A; Kurt Yilmaz N; Ali A; Schiffer CA
    Bioorg Chem; 2023 Feb; 131():106269. PubMed ID: 36446201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-active carbazole derivatives as inhibitors of the zika virus protease.
    Rassias G; Zogali V; Swarbrick CMD; Ki Chan KW; Chan SA; Gwee CP; Wang S; Kaplanai E; Canko A; Kiousis D; Lescar J; Luo D; Matsoukas MT; Vasudevan SG
    Eur J Med Chem; 2019 Oct; 180():536-545. PubMed ID: 31344613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and in vitro evaluation of West Nile virus protease inhibitors based on the 2-{6-[2-(5-phenyl-4H-{1,2,4]triazol-3-ylsulfanyl)acetylamino]benzothiazol-2-ylsulfanyl}acetamide scaffold.
    Samanta S; Lim TL; Lam Y
    ChemMedChem; 2013 Jun; 8(6):994-1001. PubMed ID: 23619931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dengue Virus NS2B/NS3 Protease Inhibitors Exploiting the Prime Side.
    Lin KH; Ali A; Rusere L; Soumana DI; Kurt Yilmaz N; Schiffer CA
    J Virol; 2017 May; 91(10):. PubMed ID: 28298600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allosteric Inhibitors of Zika Virus NS2B-NS3 Protease Targeting Protease in "Super-Open" Conformation.
    Meewan I; Shiryaev SA; Kattoula J; Huang CT; Lin V; Chuang CH; Terskikh AV; Abagyan R
    Viruses; 2023 Apr; 15(5):. PubMed ID: 37243192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-Based Macrocyclization of Substrate Analogue NS2B-NS3 Protease Inhibitors of Zika, West Nile and Dengue viruses.
    Braun NJ; Quek JP; Huber S; Kouretova J; Rogge D; Lang-Henkel H; Cheong EZK; Chew BLA; Heine A; Luo D; Steinmetzer T
    ChemMedChem; 2020 Aug; 15(15):1439-1452. PubMed ID: 32501637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of NS2B-NS3 protease and furin inhibition on West Nile and Dengue virus replication.
    Kouretova J; Hammamy MZ; Epp A; Hardes K; Kallis S; Zhang L; Hilgenfeld R; Bartenschlager R; Steinmetzer T
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):712-721. PubMed ID: 28385094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery and SAR studies of methionine-proline anilides as dengue virus NS2B-NS3 protease inhibitors.
    Zhou GC; Weng Z; Shao X; Liu F; Nie X; Liu J; Wang D; Wang C; Guo K
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6549-54. PubMed ID: 24268549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of dengue virus protease expression plasmid and in vitro protease assay for screening antiviral inhibitors.
    Lai H; Teramoto T; Padmanabhan R
    Methods Mol Biol; 2014; 1138():345-60. PubMed ID: 24696347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of NS2B-NS3 protease inhibitor that impairs Zika virus replication.
    Lin WW; Huang YJ; Wang YT; Lin YS; Mazibuko N; Chen CS; Cheng TL; Chang CS; Leu YL; Chen CY; Chuang CH
    Virus Res; 2023 May; 329():199092. PubMed ID: 36965673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploiting the unique features of Zika and Dengue proteases for inhibitor design.
    Majerová T; Novotný P; Krýsová E; Konvalinka J
    Biochimie; 2019 Nov; 166():132-141. PubMed ID: 31077760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythrosin B is a potent and broad-spectrum orthosteric inhibitor of the flavivirus NS2B-NS3 protease.
    Li Z; Sakamuru S; Huang R; Brecher M; Koetzner CA; Zhang J; Chen H; Qin CF; Zhang QY; Zhou J; Kramer LD; Xia M; Li H
    Antiviral Res; 2018 Feb; 150():217-225. PubMed ID: 29288700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profiling of flaviviral NS2B-NS3 protease specificity provides a structural basis for the development of selective chemical tools that differentiate Dengue from Zika and West Nile viruses.
    Rut W; Groborz K; Zhang L; Modrzycka S; Poreba M; Hilgenfeld R; Drag M
    Antiviral Res; 2020 Mar; 175():104731. PubMed ID: 32014497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand Accessibility Insights to the Dengue Virus NS3-NS2B Protease Assessed by Long-Timescale Molecular Dynamics Simulations.
    Kronenberger T; Sá Magalhães Serafim M; Kumar Tonduru A; Gonçalves Maltarollo V; Poso A
    ChemMedChem; 2021 Aug; 16(16):2524-2534. PubMed ID: 33899341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.